HAEMOPHILIA:血友病性关节炎患者韧带病理变化和表达观察

2021-10-29 MedSci原创 MedSci原创

嗜血性关节炎(HA)是血友病患者最常见和最严重的并发症,可导致晚期关节功能障碍和残疾。

嗜血性关节炎(HA)是血友病患者最常见和最严重的并发症,可导致晚期关节功能障碍和残疾。以往对HA的病理机制的研究主要集中在滑膜骨、软骨骨和软骨下骨病变上。目前还没有学者研究HA患者韧带组织的病理变化。HA在病因上与骨关节炎(OA)有很大的不同,我们注意到HA和OA患者在TKA手术中韧带的形态学特征有很大的不同。因此,研究血友病性关节炎(HA)患者韧带的病理变化,对于指导全膝关节置换术(TKA)中韧带的释放和探索预防韧带病变的干预措施具有重要意义。

国外一研究团队进行了一项研究,观察HA患者与骨性关节炎(OA)患者韧带组织中赖氨酸氧化酶(LOX)、基质金属蛋白酶(MMP)-1、-2、-3水平的病理变化,旨在探讨HA患者韧带组织中赖氨酸氧化酶(LOX)、基质金属蛋白酶(MMP)-1、-2、-3水平的变化。

研究采用Masson三色染色法、verhoff - van Gieson染色法、苏木精-伊红染色法,观察韧带的基本病理变化。western blot检测I型胶原、弹性蛋白、LOXs和MMP-1、-2、-3的表达水平。通过实时荧光定量PCR检测LOX和MMP-1、-2、-3 mRNA的表达水平。

结果显示与OA韧带相比,HA韧带结构更松散,间隙更宽,断裂更多,血细胞沉积和纤维间局部肥大。HA组织中LOXs和MMPmRNA表达水平上调,这与western印迹结果一致。HA患者的胶原蛋白和弹性蛋白水平也较高。

研究得出结论,HA患者的韧带代谢比OA患者更复杂,HA患者的韧带有更强的愈合和破坏过程。这种病理与铁超载和反复关节内出血引起的不平衡炎症因子有关。

原始出处:

Zheng, L, Luo, D, Li, J, et al. Pathological changes and expression of lysine oxidases and matrix metalloproteinases -1, -2, and -3 in ligaments of patients with haemophilic arthritis. Haemophilia. 2021; 1- 6. https://doi.org/10.1111/hae.14443

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2008536, encodeId=4488200853637, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu May 19 18:31:25 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266336, encodeId=565d1266336e1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Oct 31 11:31:25 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507455, encodeId=b75c150e455b2, content=<a href='/topic/show?id=16b7100010c7' target=_blank style='color:#2F92EE;'>#韧带#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100010, encryptionId=16b7100010c7, topicName=韧带)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9b19890064, createdName=juliusluan81, createdTime=Sun Oct 31 11:31:25 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2022-05-19 changfy
  2. [GetPortalCommentsPageByObjectIdResponse(id=2008536, encodeId=4488200853637, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu May 19 18:31:25 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266336, encodeId=565d1266336e1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Oct 31 11:31:25 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507455, encodeId=b75c150e455b2, content=<a href='/topic/show?id=16b7100010c7' target=_blank style='color:#2F92EE;'>#韧带#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100010, encryptionId=16b7100010c7, topicName=韧带)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9b19890064, createdName=juliusluan81, createdTime=Sun Oct 31 11:31:25 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-10-31 lmm397
  3. [GetPortalCommentsPageByObjectIdResponse(id=2008536, encodeId=4488200853637, content=<a href='/topic/show?id=1066844469' target=_blank style='color:#2F92EE;'>#HAE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8444, encryptionId=1066844469, topicName=HAE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=32d177, createdName=changfy, createdTime=Thu May 19 18:31:25 CST 2022, time=2022-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266336, encodeId=565d1266336e1, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Oct 31 11:31:25 CST 2021, time=2021-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1507455, encodeId=b75c150e455b2, content=<a href='/topic/show?id=16b7100010c7' target=_blank style='color:#2F92EE;'>#韧带#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100010, encryptionId=16b7100010c7, topicName=韧带)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9b19890064, createdName=juliusluan81, createdTime=Sun Oct 31 11:31:25 CST 2021, time=2021-10-31, status=1, ipAttribution=)]

拓展阅读

Blood:EPCR缺陷或EPCR抗体可预防血友病性关节病

EPCR缺陷可通过减少关节出血预防血友病性关节病。 单剂量EPCR封闭抗体可减轻血友病性关节病的进展。

血友病合并抑制物诊断与治疗中国指南(2023年版)

中华医学会血液学分会血栓与止血学组 · 2024-01-01

2022 MASAC 文件 273 - 血友病患者基因分型建议

国家血友病基金会的医学和科学咨询委员会 (MASAC) NHF’s Medical and Scientific Advisory Council (MASAC) · 2022-07-06

2022 MASAC 文件 272 - MASAC 关于获得许可用于治疗血友病和其他出血性疾病的产品的建议

国家血友病基金会的医学和科学咨询委员会 (MASAC) NHF’s Medical and Scientific Advisory Council (MASAC) · 2022-04-27

2022 MASAC 文件 271 - 关于在家中为血友病和抑制剂患者使用抑制剂旁路药物的建议

国家血友病基金会的医学和科学咨询委员会 (MASAC) NHF’s Medical and Scientific Advisory Council (MASAC) · 2022-04-27